Alternative strategies for the derivation of human embryonic stem cell lines and the role of dead embryos

Current Stem Cell Research and Therapy

Volumn 4, Issue 1, 2009, Pages 81-86

  Gavrilov, Svetlana ^a   Papaioannou, Virginia E ^a   Landry, Donald W ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

Alternative approaches; Arrested human embryos; ES cell derivation; hESC; Human embryonic stem cells

Indexed keywords

ADULT STEM CELL; ANALYTIC METHOD; BLASTOMERE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CELL NUCLEUS TRANSPLANTATION; EMBRYO DEATH; EMBRYONIC STEM CELL; HUMAN; MULTIPOTENT STEM CELL; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; EMBRYO RESEARCH; ETHICS; LEGAL ASPECT; METABOLISM; METHODOLOGY; MOUSE; STEM CELL TRANSPLANTATION; TRANSPLANTATION; UNITED STATES;

ADULT STEM CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; EMBRYO RESEARCH; HUMANS; MICE; NUCLEAR TRANSFER TECHNIQUES; STEM CELL TRANSPLANTATION; TISSUE AND ORGAN HARVESTING; UNITED STATES;

EID: 67849112035     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488809787169057     Document Type: Review

References (72)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7.
2. Ameen C, Strehl R, Bjorquist P, Lindahl A, Hyllner J, Sartipy P. Human embryonic stem cells: Current technologies and emerging industrial applications. Crit Rev Oncol Hematol 2008; 65(1): 54-80.
3. Cezar GG. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? Curr Opin Chem Biol 2007; 11(4): 405-9.
4. Gargett CE. Review article: stem cells in human reproduction. Reprod Sci 2007; 14(5): 405-24.
5. Klimanskaya I, Rosenthal N, Lanza R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 2008; 7(2): 131-42.
6. Green RM. Can we develop ethically universal embryonic stem-cell lines? Nat Rev Genet 2007; 8(6): 480-5.
7. Landry DW, Zucker HA. Embryonic death and the creation of human embryonic stem cells. J Clin Invest 2004; 114(9): 1184-6.
8. Lanza R, Green RM. Bush's policy stopped US gaining stem-cell lead. Nature 2005; 438(7067): 422.
9. McLaren A. A scientist's view of the ethics of human embryonic stem cell research. Cell Stem Cell 2007; 1(1): 23-6.
10. ISSCR. 2008 [cited 2008 May 8, 2008]; Available from: http://isscr.org/ public/regions/index.cfm
11. Khanna A. Blind fate vs. science. EGO magazine 2006 [cited 2008; 9 August 2006:[Available from: http://www.egothemag.com/archives/2006/08/ steml_cells_blin.htm
12. NIH. Stem Cell Information. 2008 [cited 2008 May 14, 2008]; Available from: http://stemcells.nih.gov/index.asp
13. President's Council on Bioethics. The Administration's human Emb-ryonic Stem Cell Research Funding Policy: Moral and Political Foundations. 2008 [cited 2008 May 14, 2008]; Available from: http://www.bioethics.gov/ background/es_moralfoundations.html
14. Bongso A, Tan S. Human blastocyst culture and derivation of embryonic stem cell lines. Stem Cell Rev 2005; 1(2): 87-98.
15. Allegrucci C, Young LE. Differences between human embryonic stem cell lines. Hum Reprod Update 2007; 13(2): 103-20.
16. Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat Biotechnol 2007; 25(7): 803-16.
17. Skottman H, Dilber MS, Hovatta O. The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett 2006; 580(12): 2875-8.
18. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R. Human embryonic stem cells derived without feeder cells. Lancet 2005; 365(9471): 1636-41.
19. Stojkovic P, Lako M, Stewart R, et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 2005; 23(3): 306-14.
20. Li Z, Li L. Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 2006; 31(10): 589-95.
21. Raaijmakers MH, Scadden DT. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 2008; 15(4): 301-6.
22. Trumpp A, Wiestler OD. Mechanisms of Disease: cancer stem cells - targeting the evil twin. Nat Clin Pract Oncol 2008; 5(6): 337-47.
23. Gopinath SD, Rando TA. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 2008; 7(4): 590-8.
24. Passegue E, Weisman IL. Leukemic stem cells: where do they come from? Stem Cell Rev 2005; 1(3): 181-8.
25. Charwat S, Gyongyosi M, Lang I, et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium: Current state of the art. Exp Hematol 2008; 36(6): 672-80.
26. Weissman I. Stem cell research: paths to cancer therapies and regenerative medicine. Jama 2005; 294(11): 1359-66.
27. Reddy NP, Vemuri MC, Pallu R. Isolation of stem cells from human umbilical cord blood. Methods Mol Biol 2007; 407: 149-63.
28. Seshareddy K, Troyer D, Weiss ML. Method to isolate mesenchymal-like cells from wharton's jelly of umbilical cord. Methods Cell Biol 2008; 86: 101-19.
29. Kestendjieva S, Kyurkchiev D, Tsvetkova G, et al. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 2008; 32(7): 724-32.
30. Samuel GN, Kerridge IH, O'Brien TA. Umbilical cord blood banking: public good or private benefit? Med J Aust 2008; 188(9): 533-5.
31. van de Ven C, Collins D, Bradley MB, Morris E, Cairo MS. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol 2007; 35(12): 1753-65.
32. Bieback K, Kluter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2007; 2(4): 310-23.
33. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007; 2(4): 301-9.
34. Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22(7): 1330-7.
35. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25(11): 2886-95.
36. Fong CY, Richards M, Manasi N, Biswas A, Bongso A. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online 2007; 15(6): 708-18.
37. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26(3): 591-9.
38. Delo DM, De Coppi P, Bartsch G, Jr., Atala A. Amniotic fluid and placental stem cells. Methods Enzymol 2006; 419: 426-38.
39. Siegel N, Rosner M, Hanneder M, Valli A, Hengstschlager M. Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev 2007; 3(4): 256-64.
40. Perin L, Sedrakyan S, Da Sacco S, De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol 2008; 86: 85-99.
41. Hipp J, Atala A. Sources of Stem Cells for Regenerative Medicine. Stem Cell Rev 2008; 4(1): 3-11.
42. Chiavegato A, Bollini S, Pozzobon M, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immunodeficient rat. J Mol Cell Cardiol 2007; 42(4): 746-59.
43. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5): 861-72.
44. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858): 1917-20.
45. Hurlbut WB. Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Natl Cathol Bioeth Q 2005; 5(1): 145-51.
46. Hurlbut WB. Altered nuclear transfer. N Engl J Med 2005; 352(11): 1153-4; author reply -4.
47. Jaenisch R, Meissner A. Politically correct human embryonic stem cells? N Engl J Med 2006; 354(11): 1208-9; author reply -9.
48. Meissner A, Jaenisch R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 2006; 439(7073): 212-5.
49. Chung Y, Klimanskaya I, Becker S, et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2008; 2(2): 113-7.
50. Chung Y, Klimanskaya I, Becker S, et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 2006; 439(7073): 216-9.
51. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature 2006; 444(7118): 481-5.
52. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Derivation of human embryonic stem cells from single blastomeres. Nat Protoc 2007; 2(8): 1963-72.
53. Ogilvie CM, Braude PR, Scriven PN. Preimplantation genetic diagnosis - an overview. J Histochem Cytochem 2005; 53(3): 255-60.
54. Staessen C, Platteau P, Van Assche E, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004; 19(12): 2849-58.
55. Verlinsky Y, Cohen J, Munne S, et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril 2004; 82(2): 292-4.
56. American Society for Reproductive Medicine; Practice Committee of the Society for Reproductive Technology; Practice Committee of the American Society for Reproductive Medicine. Preimplantation Genetic Testing: a Practice Committee Opinion. Fertil Steril 2007; 88(6): 1497-504.
57. Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 2000; 15(12): 2634-43.
58. Magli MC, Gianaroli L, Ferraretti AP. Chromosomal abnormalities in embryos. Mol Cell Endocrinol 2001; 183 (Suppl 1): S29-34.
59. Munne S, Chen S, Colls P, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online 2007; 14(5): 628-34.
60. Landry DW, Zucker HA, Sauer MV, Reznik M, Wiebe L. Hypocellularity and absence of compaction as criteria for embryonic death. Regen Med 2006; 1(3): 367-71.
61. Alikani M, Willadsen SM. Human blastocysts from aggregated mononucleated cells of two or more non-viable zygote-derived embryos. Reprod Biomed Online 2002; 5(1): 56-8.
62. Gavrilov SP, RW; Khalid, I; Macdonald, J; Sauer, MV; Landry DW and Papaioannou, VE. Irreversibly arrested, nonviable (organismically dead) human embryos as a source of viable cells for human embryonic stem cell (hESC) derivation. Reprod Biomed Online. In Press.
63. Bolton VN, Hawes SM, Taylor CT, Parsons JH. Development of spare human preimplantation embryos in vitro: an analysis of the correlations among gross morphology, cleavage rates, and development to the blastocyst. J In vitro Fert Embryo Transf 1989; 6(1): 30-5.
64. Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In vitro Fert Embryo Transf 1986; 3(5): 284-95.
65. Erenus M, Zouves C, Rajamahendran P, Leung S, Fluker M, Gomel V. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization. Fertil Steril 1991; 56(4): 707-10.
66. Giorgetti C, Terriou P, Auquier P, et al. Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers. Hum Reprod 1995; 10(9): 2427-31.
67. Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987; 2(8): 705-8.
68. Staessen C, Camus M, Bollen N, Devroey P, Van Steirteghem AC. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 1992; 57(3): 626-30.
69. Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1992; 7(1): 117-9.
70. Ziebe S, Petersen K, Lindenberg S, Andersen AG, Gabrielsen A, Andersen AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997; 12(7): 1545-9.
71. Lerou PH, Yabuuchi A, Huo H, et al. Human embryonic stem cell derivation from poor-quality embryos. Nat Biotechnol 2008; 27.
72. Zhang X, Stojkovic P, Przyborski S, et al. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 2006; 24(12): 2669-76.